Pharmaceutical Research, an official journal of the American Association of Pharmaceutical Scientists, presents papers which describe innovative research spanning the entire spectrum of drug discovery, development, evaluation, and regulatory approval. Small drug molecules, biotechnology products including genes, peptides, proteins and vaccines, and genetically engineered cells are an integral part of papers published here. Current emphasis of the journal includes the following areas: preformulation; drug delivery and targeting; formulation design, engineering, and processing; pharmacokinetics, pharmacodynamics, and pharmacogenomics; molecular biopharmaceutics and drug disposition; and computational biopharmaceutics, among others.
Pharmaceutical Research publishes twelve issues a year.
- Presents research spanning the entire spectrum of drug discovery, development, evaluation, and regulatory approval
- Covers pharmacodynamics, and pharmacogenomics; molecular biopharmaceutics and drug disposition; and computational biopharmaceutics and more
- An official journal of the American Association of Pharmaceutical Scientists
- 97% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again
Journal information
- Editor-in-Chief
-
- Tonglei Li
- Publishing model
- Hybrid (Transformative Journal). Learn about publishing Open Access with us
Journal metrics
- 3.242 (2019)
- Impact factor
- 3.613 (2019)
- Five year impact factor
- 25 days
- Submission to first decision
- 95 days
- Submission to acceptance
- 853,947 (2020)
- Downloads
Latest issue
Latest articles
-
-
Dried Blood Spot Technique Applied in Therapeutic Drug Monitoring of Anticancer Drugs: a Review on Conversion Methods to Correlate Plasma and Dried Blood Spot Concentrations
Authors (first, second and last of 7)
-
BSA/Silver Nanoparticle-Loaded Hydrogel Film for Local Photothermal Treatment of Skin Cancer
Authors (first, second and last of 10)
-
Characterization of Biological Material Adsorption to the Surface of Nanoparticles without a Prior Separation Step: a Case Study of Glioblastoma-Targeting Peptide and Lipid Nanocapsules
Authors (first, second and last of 8)
-
Journal updates
-
AAPS Pharmaceutical Research Meritorious Manuscript Award
AAPS Pharmaceutical Research Meritorious Manuscript Award Recognizing outstanding achievement in the pharmaceutical sciences as demonstrated by the author(s) in the quality and originality of a manuscript published in Pharmaceutical Research. Watch the video here.
Awardee/Corresponding Author: Dennis Douroumis, Ph.D., University of Greenwich Co-Authors: Nicolaos Scoutaris, Ph.D. and Steven A. Ross, Ph.D.
-
Featured article
Repurposing of kinase inhibitors for treatment of COVID-19
There are three major needs that have yet to be met for effective management of COVID19 disease: 1) anti-viral therapies that limit viral transmission, cell entry, and replication, 2) therapies that attenuate the non-productive immune response and thus decrease end-organ damage, and 3) therapies that have an anti-fibrotic effect in patients with ARDS and thus decrease long-term sequelae of disease. Read the article above for the full review and proposal. -
COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
-
Announcing new Editor-in-Chief of AAPS Open: Dr. Andrea Allmendinger
AAPS Open is proud to announce new Editor-in-Chief Dr. Andrea Allmendinger. Dr. Allmendinger obtained her PhD in Pharmaceutical Technology from the University of Basel and joined the Pharmaceutical Development department of Roche/Genentech in Basel in 2013, where she is responsible for formulation and process development for clinical Phase I-III projects and commercial transfer activities for both large molecules and for synthetic drugs.
Societies, partners and affiliations
About this journal
- Electronic ISSN
- 1573-904X
- Print ISSN
- 0724-8741
- Abstracted and indexed in
-
- AGRICOLA
- BIOSIS
- Biological Abstracts
- CAB Abstracts
- CNKI
- Chemical Abstracts Service (CAS)
- Chimica
- Current Contents/ Life Sciences
- Dimensions
- EBSCO Academic Search
- EBSCO Biomedical Reference Collection
- EBSCO Discovery Service
- EBSCO STM Source
- EMBASE
- Google Scholar
- INSPEC
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Meta
- Naver
- OCLC WorldCat Discovery Service
- Pathway Studio
- ProQuest Agricultural & Environmental Science Database
- ProQuest Biological Science Database
- ProQuest Biotechnology Research Abstracts
- ProQuest Central
- ProQuest Engineering
- ProQuest Environmental Science
- ProQuest Health & Medical Collection
- ProQuest Health Research Premium Collection
- ProQuest Materials Science and Engineering Database
- ProQuest Medical Database
- ProQuest Natural Science Collection
- ProQuest Neurosciences Abstracts
- ProQuest Nursing & Allied Health Database
- ProQuest Pharma Collection
- ProQuest SciTech Premium Collection
- ProQuest Technology Collection
- ProQuest Toxicology Abstracts
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index
- Science Citation Index Expanded (SciSearch)
- TD Net Discovery Service
- UGC-CARE List (India)
- Copyright information
-
© Springer Science+Business Media, LLC, part of Springer Nature